
| NAME | DATE | TM | OPP | MIN | PTS | REB | AST | STL | BLK | FGM | FGA | FG% | 3PM | 3PA | 3P% | FTM | FTA | FT% | TS% | OREB | DREB | TOV | PF | +/- | |||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 |  |  F. VanVleet   | 12/18/2016    |  TOR | @    |  ORL | 23    | 4    | 2    | 4    | 3    | 0    | 2    | 5    | 40.0    | 0    | 1    | 0.0    | 0    | 0    | 40.0    | 0    | 2    | 0    | 3    | +19    | |
| 2 |  |  F. VanVleet   | 1/29/2017    |  TOR | vs    |  ORL | 3    | 0    | 0    | 0    | 0    | 0    | 0    | 0    | 0    | 0    | 0    | 0    | 0    | 0    | 0    | 1    | -3    | ||||
| 3 |  |  F. VanVleet   | 2/3/2017    |  TOR | @    |  ORL | 23    | 15    | 3    | 3    | 1    | 0    | 5    | 12    | 41.7    | 2    | 4    | 50.0    | 3    | 3    | 100.0    | 56.3    | 1    | 2    | 2    | 2    | +6    | 
| 4 |  |  F. VanVleet   | 3/27/2017    |  TOR | vs    |  ORL | 2    | 1    | 1    | 0    | 0    | 0    | 0    | 0    | 0    | 0    | 1    | 2    | 50.0    | 56.8    | 0    | 1    | 0    | 0    | +1    | ||
| 5 |  |  F. VanVleet   | 2/28/2018    |  TOR | @    |  ORL | 27    | 12    | 3    | 3    | 2    | 0    | 4    | 9    | 44.4    | 3    | 4    | 75.0    | 1    | 2    | 50.0    | 60.7    | 0    | 3    | 2    | 1    | +9    | 
| 6 |  |  F. VanVleet   | 4/8/2018    |  TOR | vs    |  ORL | 9    | 0    | 0    | 3    | 0    | 1    | 0    | 1    | 0.0    | 0    | 1    | 0.0    | 0    | 0    | 0.0    | 0    | 0    | 2    | 1    | +6    | |
| 7 |  |  F. VanVleet   | 11/20/2018    |  TOR | @    |  ORL | 26    | 4    | 2    | 5    | 1    | 0    | 1    | 5    | 20.0    | 0    | 1    | 0.0    | 2    | 2    | 100.0    | 34.0    | 0    | 2    | 1    | 1    | +6    | 
| 8 |  |  F. VanVleet   | 12/28/2018    |  TOR | @    |  ORL | 23    | 11    | 1    | 2    | 1    | 1    | 3    | 12    | 25.0    | 2    | 6    | 33.3    | 3    | 4    | 75.0    | 40.0    | 0    | 1    | 0    | 1    | -13    | 
| 9 |  |  F. VanVleet   | 4/1/2019    |  TOR | vs    |  ORL | 27    | 10    | 0    | 7    | 2    | 2    | 3    | 6    | 50.0    | 2    | 4    | 50.0    | 2    | 2    | 100.0    | 72.7    | 0    | 0    | 2    | 1    | +16    | 
| 10 |  |  F. VanVleet   | 10/28/2019    |  TOR | vs    |  ORL | 39    | 14    | 5    | 6    | 2    | 0    | 3    | 14    | 21.4    | 1    | 7    | 14.3    | 7    | 7    | 100.0    | 41.0    | 0    | 5    | 3    | 0    | +8    | 
| 11 |  |  F. VanVleet   | 11/20/2019    |  TOR | vs    |  ORL | 35    | 24    | 1    | 7    | 2    | 0    | 10    | 19    | 52.6    | 1    | 5    | 20.0    | 3    | 4    | 75.0    | 57.8    | 0    | 1    | 3    | 2    | +8    | 
| 12 |  |  F. VanVleet   | 11/29/2019    |  TOR | @    |  ORL | 41    | 22    | 5    | 4    | 7    | 0    | 7    | 20    | 35.0    | 5    | 12    | 41.7    | 3    | 5    | 60.0    | 49.5    | 1    | 4    | 3    | 1    | +9    | 
| 13 |  |  F. VanVleet   | 8/5/2020    |  TOR | @    |  ORL | 35    | 21    | 4    | 10    | 1    | 0    | 8    | 13    | 61.5    | 2    | 5    | 40.0    | 3    | 4    | 75.0    | 71.1    | 0    | 4    | 0    | 2    | +11    | 
| 14 |  |  F. VanVleet   | 1/31/2021    |  TOR | vs    |  ORL | 31    | 9    | 2    | 5    | 1    | 0    | 4    | 12    | 33.3    | 1    | 7    | 14.3    | 0    | 0    | 37.5    | 0    | 2    | 4    | 2    | +17    | |
| 15 |  |  F. VanVleet   | 2/2/2021    |  TOR | @    |  ORL | 37    | 54    | 3    | 2    | 3    | 3    | 17    | 23    | 73.9    | 11    | 14    | 78.6    | 9    | 9    | 100.0    | 100.1    | 0    | 3    | 1    | 2    | +20    | 
| 16 |  |  F. VanVleet   | 4/16/2021    |  TOR | vs    |  ORL | 23    | 6    | 1    | 6    | 1    | 2    | 3    | 11    | 27.3    | 0    | 6    | 0.0    | 0    | 0    | 27.3    | 0    | 1    | 2    | 2    | 0    | |
| 17 |  |  F. VanVleet   | 10/29/2021    |  TOR | vs    |  ORL | 40    | 19    | 1    | 6    | 0    | 0    | 7    | 16    | 43.8    | 3    | 10    | 30.0    | 2    | 3    | 66.7    | 54.8    | 0    | 1    | 1    | 3    | 0    | 
| 18 |  |  F. VanVleet   | 4/1/2022    |  TOR | @    |  ORL | 39    | 19    | 4    | 3    | 6    | 1    | 7    | 19    | 36.8    | 5    | 16    | 31.3    | 0    | 0    | 50.0    | 1    | 3    | 3    | 2    | +30    | |
| 19 |  |  F. VanVleet   | 12/3/2022    |  TOR | vs    |  ORL | 37    | 13    | 2    | 7    | 3    | 0    | 4    | 11    | 36.4    | 3    | 8    | 37.5    | 2    | 3    | 66.7    | 52.8    | 0    | 2    | 4    | 4    | +20    | 
| 20 |  |  F. VanVleet   | 12/9/2022    |  TOR | @    |  ORL | 37    | 19    | 2    | 6    | 1    | 1    | 5    | 14    | 35.7    | 2    | 9    | 22.2    | 7    | 9    | 77.8    | 52.9    | 0    | 2    | 2    | 0    | -15    | 
| 21 |  |  F. VanVleet   | 12/11/2022    |  TOR | @    |  ORL | 42    | 20    | 4    | 7    | 4    | 0    | 4    | 11    | 36.4    | 2    | 7    | 28.6    | 10    | 12    | 83.3    | 61.4    | 1    | 3    | 1    | 4    | -5    | 
| 22 |  |  F. VanVleet   | 2/14/2023    |  TOR | vs    |  ORL | 35    | 10    | 0    | 15    | 3    | 1    | 3    | 12    | 25.0    | 3    | 9    | 33.3    | 1    | 1    | 100.0    | 40.2    | 0    | 0    | 5    | 3    | +14    | 
| 23 |  |  F. VanVleet   | 10/25/2023    |  HOU | @    |  ORL | 34    | 14    | 1    | 5    | 1    | 0    | 5    | 13    | 38.5    | 4    | 6    | 66.7    | 0    | 0    | 53.8    | 0    | 1    | 3    | 0    | -3    | |
| 24 |  |  F. VanVleet   | 4/9/2024    |  HOU | vs    |  ORL | 38    | 37    | 8    | 6    | 1    | 1    | 13    | 22    | 59.1    | 6    | 11    | 54.5    | 5    | 6    | 83.3    | 75.1    | 1    | 7    | 2    | 4    | +21    | 
| 25 |  |  F. VanVleet   | 3/19/2025    |  HOU | @    |  ORL | 36    | 19    | 6    | 3    | 1    | 0    | 4    | 15    | 26.7    | 3    | 9    | 33.3    | 8    | 8    | 100.0    | 51.3    | 0    | 6    | 1    | 3    | -1    | 
| Average | 29.6 | 15.1 | 2.4 | 5.0 | 1.9 | 0.5 | 4.9 | 11.8 | 41.4 | 2.4 | 6.5 | 37.7 | 2.9 | 3.4 | 83.7 | 56.6 | 0.2 | 2.2 | 1.9 | 1.8 | 7.2 | ||||||
| Total | 740 | 377 | 61 | 125 | 47 | 13 | 122 | 295 | 41.4 | 61 | 162 | 37.7 | 72 | 86 | 83.7 | 56.6 | 5 | 56 | 47 | 45 | +181 | 
ORTG
116.2
14th
DRTG
122.3
28th
NETRTG
-6.1
23rd
3P%
40.1
5th